Role of oxytocin in chronic visceral pain [ 2014 - 2016 ]

Also known as: Stable oxytocin analogues - potential treatment for irritable bowel syndrome

Research Grant

[Cite as]

Researchers: Prof Paul Alewood (Principal investigator) ,  A/Pr Stuart Brierley

Brief description Irritable Bowel Syndrome (IBS) is one of the leading causes of chronic pain both world-wide and in Australia for which there is a lack of treatments. Chronic pain arises from nerve fibres in the colon wall, which fail to 'reset' back to normal following inflammation. Targeting these nerve endings with drugs is a key advance in IBS treatment. This project will identify selective oxytocin analogues that act in the colon to lower pain in sensory nerves thus providing efficacious pain relief in IBS.

Funding Amount $AUD 683,040.36

Funding Scheme Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]